España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Juan Spínelli
DEA Faces Lawsuit Alleging Bias In Marijuana Rescheduling Process
Researcher David Heldreth sues DEA over alleged legal violations in marijuana rescheduling, citing bias and exclusion of small businesses and Native American tribes.
Patents Reveal New Prodrugs For Psilocin, Promising Reliable Mental Health Treatments
Recent patents on novel psychedelic prodrugs show promise in enhancing stability and efficacy, offering new hope for effective mental health treatments.
Relaxation Emerges As Strongest Predictor Of Psychedelic Therapy Benefits, Study
Study reveals relaxation, not mystical experiences, as the main factor in the success of psychedelic therapy for treatment-resistant depression.
U.S. Election Stress Fuels Demand For Psychedelic-Assisted Therapy
Post-election stress has driven a surge in Americans seeking psychedelic therapy for relief, with clinics reporting record appointments.
Psychedelic Mushrooms Market Poised For $3.3 Billion Surge By 2031
Psychedelic mushrooms market to reach $3.3 billion by 2031, due to rising demand, regulatory changes & growing psilocybin acceptance.
Veterans Deserve Access To Life-Changing Psychedelics Therapy: A Vital Solution For PTSD And Healing
Veterans seeking PTSD relief face legal challenges in accessing psychedelic therapies. Will these treatments become available to those in need?
UK Breaks New Ground With First Government-Backed Psilocybin Therapy For Opioid Crisis
A UK-funded study will explore psilocybin's potential to treat opioid addiction, with a focus on reducing high relapse rates.
California College Launches Nation's First Psychedelic Studies Degree For Undergraduates
CIIS launches the first undergraduate degree in psychedelic studies, training students to meet the demand for therapeutic expertise.
Pro Golfers Turn To Psychedelics For Focus Boost And Anxiety Relief
Pro golfers are using psychedelics like psilocybin and DMT to sharpen mental performance, signaling a new trend in sports wellness.
Elon Musk And Joe Rogan Criticize Psychedelics And Big Pharma's Legacy Of Profit Over Public Health
Joe Rogan and Elon Musk discuss the pharma industry's history of prioritizing profits over health, sparking debate on drug safety and ethics.
Massachusetts Votes Down Psychedelic Therapy After Hard-Fought Legalization Campaign, What's Next?
Massachusetts voters have rejected Question 4, which sought to legalize and regulate certain psychedelics for therapeutic use.
Americans Favor Psilocybin For Mental Health Treatment, Study Finds
Most Americans support psilocybin use for mental health and well-being, a new study shows, marking a shift in attitudes toward psychedelics.
2024 Election Spotlight: Massachusetts And Oregon Tackle Psychedelics Reform
MA and OR voters decide on groundbreaking psychedelic policies in 2024, with measures that could redefine mental health treatment nationwide.
Marijuana Capital Markets: Bright 2025 Outlook Amid Regulatory Shifts
Federal reform and banking access may drive cannabis capital markets in 2025. Discover why upcoming election changes could boost the industry.
Cannabist Co. Joins Forces With 'Weed For Warriors' In Veterans Day Cannabis Donation Drive
Cannabist Company partners with Weed for Warriors to support veteran access to medical cannabis through a Veterans Day donation drive across 12 U.S. states.
JD Vance Considers Psychedelic Therapy For Vets: Insights From Joe Rogan Interview
JD Vance's discussed his views on therapeutic psychedelics for veterans, and his "live and let live" approach to drug policy.
EXCLUSIVE: Mike Tyson And Stündenglass Unveil The TYSON 2.0 Modül + Dok Travel Set
TYSON 2.0 Modül + Dok Deluxe Travel Set is a portable smoking device launched by Stündenglass and Mike Tyson to celebrate his fight with Jake Paul.
As Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve Cash
Compass Pathways delays key Phase 3 psilocybin trial readouts, triggering a 30% workforce reduction amid efforts to conserve cash and refocus.
FDA Public Meeting Reveals Federal Support For Psychedelics In PTSD Care
Determining Who's 'Too High To Drive' Poses Challenge For Police Nationwide
Police face challenges in assessing cannabis impairment for drivers, relying on outdated methods without a reliable, standardized test.